244 related articles for article (PubMed ID: 30165384)
21. Hot topics in DNA repair: the molecular basis for different disease states caused by mutations in TFIIH and XPG.
Schärer OD
DNA Repair (Amst); 2008 Feb; 7(2):339-44. PubMed ID: 18077223
[TBL] [Abstract][Full Text] [Related]
22. Human cancer and DNA repair-deficient diseases.
Sarasin A; Stary A
Cancer Detect Prev; 1997; 21(5):406-11. PubMed ID: 9307843
[TBL] [Abstract][Full Text] [Related]
23. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
[TBL] [Abstract][Full Text] [Related]
24. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
Kirschner K; Melton DW
Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
[TBL] [Abstract][Full Text] [Related]
25. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
Brooks PJ
Neuroscience; 2007 Apr; 145(4):1407-17. PubMed ID: 17184928
[TBL] [Abstract][Full Text] [Related]
26. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease.
Sijbers AM; de Laat WL; Ariza RR; Biggerstaff M; Wei YF; Moggs JG; Carter KC; Shell BK; Evans E; de Jong MC; Rademakers S; de Rooij J; Jaspers NG; Hoeijmakers JH; Wood RD
Cell; 1996 Sep; 86(5):811-22. PubMed ID: 8797827
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F.
van Vuuren AJ; Appeldoorn E; Odijk H; Yasui A; Jaspers NG; Bootsma D; Hoeijmakers JH
EMBO J; 1993 Sep; 12(9):3693-701. PubMed ID: 8253091
[TBL] [Abstract][Full Text] [Related]
28. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
Ito S; Kuraoka I; Chymkowitch P; Compe E; Takedachi A; Ishigami C; Coin F; Egly JM; Tanaka K
Mol Cell; 2007 Apr; 26(2):231-43. PubMed ID: 17466625
[TBL] [Abstract][Full Text] [Related]
29. Xeroderma pigmentosum group F protein binds to Eg5 and is required for proper mitosis: implications for XP-F and XFE.
Tan LJ; Saijo M; Kuraoka I; Narita T; Takahata C; Iwai S; Tanaka K
Genes Cells; 2012 Mar; 17(3):173-85. PubMed ID: 22353549
[TBL] [Abstract][Full Text] [Related]
30. Fanconi anemia with sun-sensitivity caused by a Xeroderma pigmentosum-associated missense mutation in XPF.
Popp I; Punekar M; Telford N; Stivaros S; Chandler K; Minnis M; Castleton A; Higham C; Hopewell L; Gareth Evans D; Raams A; Theil AF; Meyer S; Schindler D
BMC Med Genet; 2018 Jan; 19(1):7. PubMed ID: 29325523
[TBL] [Abstract][Full Text] [Related]
31. Mutations in Cockayne Syndrome-Associated Genes (Csa and Csb) Predispose to Cisplatin-Induced Hearing Loss in Mice.
Rainey RN; Ng SY; Llamas J; van der Horst GT; Segil N
J Neurosci; 2016 Apr; 36(17):4758-70. PubMed ID: 27122034
[TBL] [Abstract][Full Text] [Related]
32. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
[TBL] [Abstract][Full Text] [Related]
33. Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing.
Calmels N; Greff G; Obringer C; Kempf N; Gasnier C; Tarabeux J; Miguet M; Baujat G; Bessis D; Bretones P; Cavau A; Digeon B; Doco-Fenzy M; Doray B; Feillet F; Gardeazabal J; Gener B; Julia S; Llano-Rivas I; Mazur A; Michot C; Renaldo-Robin F; Rossi M; Sabouraud P; Keren B; Depienne C; Muller J; Mandel JL; Laugel V
Orphanet J Rare Dis; 2016 Mar; 11():26. PubMed ID: 27004399
[TBL] [Abstract][Full Text] [Related]
34. Nucleotide excision repair and human syndromes.
de Boer J; Hoeijmakers JH
Carcinogenesis; 2000 Mar; 21(3):453-60. PubMed ID: 10688865
[TBL] [Abstract][Full Text] [Related]
35. Differential processing of UV mimetic and interstrand crosslink damage by XPF cell extracts.
Zhang N; Zhang X; Peterson C; Li L; Legerski R
Nucleic Acids Res; 2000 Dec; 28(23):4800-4. PubMed ID: 11095693
[TBL] [Abstract][Full Text] [Related]
36. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
[TBL] [Abstract][Full Text] [Related]
37. Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy.
Graham JM; Anyane-Yeboa K; Raams A; Appeldoorn E; Kleijer WJ; Garritsen VH; Busch D; Edersheim TG; Jaspers NG
Am J Hum Genet; 2001 Aug; 69(2):291-300. PubMed ID: 11443545
[TBL] [Abstract][Full Text] [Related]
38. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription.
Schäfer A; Schubert S; Gratchev A; Seebode C; Apel A; Laspe P; Hofmann L; Ohlenbusch A; Mori T; Kobayashi N; Schürer A; Schön MP; Emmert S
J Invest Dermatol; 2013 Jul; 133(7):1841-9. PubMed ID: 23370536
[TBL] [Abstract][Full Text] [Related]
39. Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin.
Aune GJ; Takagi K; Sordet O; Guirouilh-Barbat J; Antony S; Bohr VA; Pommier Y
Clin Cancer Res; 2008 Oct; 14(20):6449-55. PubMed ID: 18927284
[TBL] [Abstract][Full Text] [Related]
40. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.
Nouspikel T; Lalle P; Leadon SA; Cooper PK; Clarkson SG
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3116-21. PubMed ID: 9096355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
